New data indicates that retatrutide, a dual-action medication, could represent a major advance in size management. This drug combines the actions of a GLP-1 analog and a GIP analog, seemingly offering a https://naturalbookmarks.com/story21687619/this-new-breakthrough-for-size-regulation